Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Work In Process (2023 - 2026)

Adagio Medical Holdings (ADGM) reported Work In Process of $203000.0 for Q1 2026, up 93.33% year-over-year from $105000.0 in Q1 2025, and up 24.54% on a QoQ basis from $163000.0 in Q4 2025.

Adagio Medical Holdings (ADGM) has 4 years of Work In Process data on file, last reported at $203000.0 in Q1 2026.

  • Quarterly Work In Process rose 93.33% year-over-year to $203000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203000.0 (up 93.33% YoY) and the FY2025 annual result came in at $163000.0, down 57.99% from the prior year.
  • Work In Process improved to $203000.0 in Q1 2026 per ADGM's latest filing, from $163000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $509000.0 in Q3 2024 and bottomed at $82000.0 in Q3 2025.
  • The 4-year median for Work In Process is $180000.0 (2023), against an average of $217375.0.
  • The widest annual swing landed in 2024, when Work In Process surged 96.95%; it then sank 83.89% in 2025.
  • Tracing ADGM's Work In Process over 4 years: stood at $197000.0 in 2023, then surged by 96.95% to $388000.0 in 2024, then plunged by 57.99% to $163000.0 in 2025, then climbed by 24.54% to $203000.0 in 2026.
  • Per Business Quant, the three latest ADGM Work In Process figures stand at $203000.0 (Q1 2026), $163000.0 (Q4 2025), and $82000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Adagio Medical Holdings 16.86 Mn 3.95 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 203,000.00
Dec 31, 2025 163,000.00
Sep 30, 2025 82,000.00
Jun 30, 2025 92,000.00
Mar 31, 2025 105,000.00
Dec 31, 2024 388,000.00
Sep 30, 2024 509,000.00
Dec 31, 2023 197,000.00